natamycin

(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0^5,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid

NCXMLFZGDNKEPB-FFPOYIOWSA-N CHEBI:7488 0 Reactome links 3 studies

3 Observed studies

3 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: NCXMLFZGDNKEPB-FFPOYIOWSA-N
InChI Key: NCXMLFZGDNKEPB-FFPOYIOWSA-N
IUPAC name: (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0^5,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
Preferred name: natamycin
INN name: natamycin
Synonym: pimaricin
ChEBI: CHEBI:7488

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles